asa glp 1 guidelines Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 GLP-1 drugs and aspiration risk
Description
Primary culture and phenotyping of murine chondrocytes
Patients taking GLP-1 receptor agonists in combination with insulin or sulfonylureas face increased hypoglycemia risk and should be counseled to check blood glucose when experiencing these symptoms
In addition, its high molecular weight (57 kDa) prevents renal clearance and prolongs its half-life (133)
Studies conducted in isolated rat islets have shown that GIP does, in fact, increase intracellular cAMP levels, which in turn stimulate glucagon secretion [18]
